The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Treatment outcome in a single institution cohort.

The article discusses the study the treatment of patient with metastatic head and neck squamous cell carcinoma. Topics discussed include method of the study which include analysis of patients with the history of metastasis, the intake of cisplatin and cetuximab drugs, and the analysis of overall survival (OS) and progression-free survival (PFS) which were performed using the Kaplan-Meier method.